These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35734401)

  • 1. Population Pharmacokinetics of Vancomycin in Pregnant Women.
    Goyal RK; Moffett BS; Gobburu JVS; Al Mohajer M
    Front Pharmacol; 2022; 13():873439. PubMed ID: 35734401
    [No Abstract]   [Full Text] [Related]  

  • 2. Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.
    Belabbas T; Yamada T; Egashira N; Hirota T; Suetsugu K; Mori Y; Kato K; Akashi K; Ieiri I
    J Infect Chemother; 2023 Apr; 29(4):391-400. PubMed ID: 36682608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-based Evaluation of the Clinical and Microbiological Efficacy of Vancomycin: A Prospective Study of Chinese Adult In-house Patients.
    Shen K; Yang M; Fan Y; Liang X; Chen Y; Wu J; Yu J; Zhang H; Wang R; Zhang F; Hang J; Wen X; Li H; Shen L; Zhang Z; Wu S; Shen B; Huang W; Chang C; Shen Y; Ren H; Yuan Q; Song X; Luo X; Zhang H; Yang W; Yang J; Zhang J
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S256-S262. PubMed ID: 30423042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock.
    Katip W; Jaruratanasirikul S; Pattharachayakul S; Wongpoowarak W; Jitsurong A; Lucksiri A
    Infect Drug Resist; 2016; 9():253-260. PubMed ID: 27920562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review.
    Chung E; Sen J; Patel P; Seto W
    Clin Pharmacokinet; 2021 Aug; 60(8):985-1001. PubMed ID: 34002357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Pharmacometrics in Pharmacotherapy: Open-Source Software for Vancomycin Therapeutic Drug Management.
    Bae SH; Yim DS; Lee H; Park AR; Kwon JE; Sumiko H; Han S
    Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31075931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
    Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
    Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics and Model-Based Dose Optimization of Vancomycin in Sudanese Adult Patients with Renal Impairment.
    Ahmed KA; Ibrahim A; Gonzalez D; Nur AO
    Drug Des Devel Ther; 2024; 18():81-95. PubMed ID: 38260090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
    Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
    J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new population pharmacokinetic model for vancomycin in patients with variable renal function: Therapeutic drug monitoring based on extended covariate model using CKD-EPI estimation.
    Kim DJ; Lee DH; Ahn S; Jung J; Kiem S; Kim SW; Shin JG
    J Clin Pharm Ther; 2019 Oct; 44(5):750-759. PubMed ID: 31228353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants.
    Song L; He CY; Yin NG; Liu F; Jia YT; Liu Y
    Oncotarget; 2017 Dec; 8(62):105211-105221. PubMed ID: 29285245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.
    Liu Q; Huang H; Xu B; Li D; Liu M; Shaik IH; Wu X
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.
    Moffett BS; Morris J; Munoz F; Arikan AA
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1089-1097. PubMed ID: 30937470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AUC-Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis.
    Lanke S; Yu T; Rower JE; Balch AH; Korgenski EK; Sherwin CM
    J Clin Pharmacol; 2017 Jan; 57(1):77-84. PubMed ID: 27291466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
    Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
    J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan.
    Munir MM; Rasheed H; Khokhar MI; Khan RR; Saeed HA; Abbas M; Ali M; Bilal R; Nawaz HA; Khan AM; Qamar S; Anjum SM; Usman M
    Front Pharmacol; 2021; 12():721819. PubMed ID: 34858169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.